Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2020

Apr 14, 2020

3091_iss_2020-04-14_f7d5066f-52d8-4bf7-8975-57fa5f0cb44e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Oncopeptides AB

Holder

Swedbank Robur Fonder AB

Instrument

Instrument Aktier SE0009414576
Before the transaction
Shares 2,757,502
Voting rights 2,757,502
Transaction
Reason for major shareholding notification Buy
Date 09/04/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,807,502
Directly held voting rights 2,807,502
Indirectly held voting rights 0
Percentage
Directly held shares 5.07 %
Directly held voting rights 5.07 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.07 % 2,807,502
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.07 % 2,807,502
Published 14/04/2020 15:35
Contact
Name Mia Metso Ekberg
Phone 08-58597525
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25